Breast: Page 44

ECR: AI cuts radiologist workload by prioritizing mammography

By Kate Madden Yee

Using an artificial intelligence (AI) algorithm to triage screening mammography exams for interpretation both cuts radiologists' recall rates and their daily reading list, according to a presentation delivered on July 16 at ECR 2022.

July 17, 2022

ECR: Don't fear lymphadenopathy after vaccination

By Amerigo Allegretto

Researchers continue to gain ground in understanding lymphadenopathy caused by the COVID-19 vaccines, and several presenters discussed their findings on the topic on July 13 at ECR 2022.

July 14, 2022

ECR: U.S. expert urges annual breast screening starting at 40

By Kate Madden Yee

VIENNA - U.S. research shows that annual breast cancer screening starting at age 40 is the most effective way to reduce mortality from the disease, according to a presentation delivered July 13 at ECR 2022 in Vienna.

July 13, 2022

ECR: What will breast imaging look like in 2025?

By Amerigo Allegretto

Anything can happen three years from now, but that's not stopping breast imaging experts from making predictions for modalities within the next few years at the ECR in Vienna.

July 13, 2022

ECR: How has COVID affected cancer screening in Europe?

By Kate Madden Yee

VIENNA - The COVID-19 pandemic dramatically affected how healthcare was delivered in Europe, and oncology screening programs were not immune from its impact, according to a panel of experts that convened on July 13 at ECR 2022 in Vienna.

July 12, 2022

Mass enhancement on contrast mammography tied to malignancy

By Amerigo Allegretto

Mass enhancement on recombined images using contrast-enhanced mammography (CEM) is associated with malignancy, especially when linked to low-energy findings, a study published July 12 in Radiology found.

July 12, 2022

AI of ultrasound predicts lymph node reactions to COVID vax

By Amerigo Allegretto

Artificial intelligence (AI) trained with ultrasound images can help differentiate between malignant lymph nodes from benign nodes that react as a side effect of COVID-19 vaccination, found researchers in a study published July 7 in the European Journal of Radiology.

July 10, 2022

COVID pandemic cut breast cancer screening volume by half

By Amerigo Allegretto

The COVID-19 pandemic led to breast cancer screening worldwide falling by nearly half, a study published July 7 in JAMA Oncology has found. This could lead to a rise in deaths from cancer that could have been avoidable, researchers say.

July 7, 2022

DWI-MRI predicts whether women's DCIS will upstage after surgery

By Kate Madden Yee

Preoperative diffusion-weighted MRI (DWI-MRI) is effective for predicting whether biopsy-confirmed ductal carcinoma in situ (DCIS) will be reclassified as invasive cancer after surgery, a study published July 5 in Radiology has found.

July 6, 2022

Week in Review: Ditching lead aprons | CMS rethinks PET payment limits | Contrast mammo vs. breast MRI

By Brian Casey

June 30, 2022

FDA yanks MQSA certificate from imaging facility in Md.

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has revoked the certification under the Mammography Quality Standards Act (MQSA) of a mammography facility in Maryland that has a history of problems with image quality.

June 30, 2022

Clinical breast exam may not be needed for follow-up

By Amerigo Allegretto

Less than 3% of early-stage breast cancer patients experience disease recurrence during five years of follow-up, and recurrence is more likely to be detected through mammography or patient symptoms than through physical clinical breast exams, a study published June 28 in Clinical Breast Cancer found.

June 30, 2022

Previous Page

Page 44 of 578

Next Page